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Abstract: OBJECTIVES To develop and validate an artificial intelligence algorithm to decide on the
necessity of dynamic contrast-enhanced sequences (DCE) in prostate MRI. METHODS This study was
approved by the institutional review board and requirement for study-specific informed consent was
waived. A convolutional neural network (CNN) was developed on 300 prostate MRI examinations. Con-
sensus of two expert readers on the necessity of DCE acted as reference standard. The CNN was validated
in a separate cohort of 100 prostate MRI examinations from the same vendor and 31 examinations from a
different vendor. Sensitivity/specificity were calculated using ROC curve analysis and results were com-
pared to decisions made by a radiology technician. RESULTS The CNN reached a sensitivity of 94.4%
and specificity of 68.8% (AUC: 0.88) for the necessity of DCE, correctly assigning 44%/34% of patients to
a biparametric/multiparametric protocol. In 2% of all patients, the CNN incorrectly decided on omitting
DCE. With a technician reaching a sensitivity of 63.9% and specificity of 89.1%, the use of the CNN would
allow for an increase in sensitivity of 30.5%. The CNN achieved an AUC of 0.73 in a set of examinations
from a different vendor. CONCLUSIONS The CNN would have correctly assigned 78% of patients to
a biparametric or multiparametric protocol, with only 2% of all patients requiring re-examination to
add DCE sequences. Integrating this CNN in clinical routine could render the requirement for on-table
monitoring obsolete by performing contrast-enhanced MRI only when needed.
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Improving workflow in prostate MRI: 
AI-based decision-making on biparametric 
or multiparametric MRI
Andreas M. Hötker1* , Raffaele Da Mutten1, Anja Tiessen1, Ender Konukoglu2 and Olivio F. Donati1 
Abstract 
Objectives: To develop and validate an artificial intelligence algorithm to decide on the necessity of dynamic 
contrast-enhanced sequences (DCE) in prostate MRI.
Methods: This study was approved by the institutional review board and requirement for study-specific informed 
consent was waived. A convolutional neural network (CNN) was developed on 300 prostate MRI examinations. 
Consensus of two expert readers on the necessity of DCE acted as reference standard. The CNN was validated in a 
separate cohort of 100 prostate MRI examinations from the same vendor and 31 examinations from a different ven-
dor. Sensitivity/specificity were calculated using ROC curve analysis and results were compared to decisions made by 
a radiology technician.
Results: The CNN reached a sensitivity of 94.4% and specificity of 68.8% (AUC: 0.88) for the necessity of DCE, correctly 
assigning 44%/34% of patients to a biparametric/multiparametric protocol. In 2% of all patients, the CNN incorrectly 
decided on omitting DCE. With a technician reaching a sensitivity of 63.9% and specificity of 89.1%, the use of the 
CNN would allow for an increase in sensitivity of 30.5%. The CNN achieved an AUC of 0.73 in a set of examinations 
from a different vendor.
Conclusions: The CNN would have correctly assigned 78% of patients to a biparametric or multiparametric protocol, 
with only 2% of all patients requiring re-examination to add DCE sequences. Integrating this CNN in clinical routine 
could render the requirement for on-table monitoring obsolete by performing contrast-enhanced MRI only when 
needed.
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Key points
• AI helps in automated decision-making between 
biparametric and multiparametric prostate MRI pro-
tocols.
• AI would have correctly assigned 78% of patients to a 
biparametric/multiparametric protocol.
• Re-examinations would have only been necessary in 
2% of all patients.
• The performance of the trained network differed 
slightly between MRIs from different vendors.
Background
Prostate MRI has shown considerable clinical value in 
detection and staging of prostate cancer and is part of 
clinical routine in most institutions worldwide [1–4]. 
Conventionally, “multiparametric” prostate MRI consists 
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and dynamic contrast-enhanced (DCE) sequences [5]. 
Recently, the use of an abbreviated MRI protocol with-
out application of a contrast agent (termed “biparamet-
ric MRI”) has been proposed and several investigations 
have reported a comparable performance of the proto-
col in cancer detection compared to the complete mul-
tiparametric protocol [6–11]. Omittance of DCE-MRI 
from the acquisition results in shorter examinations, an 
optimization duly needed in times of increasing demand 
for prostate MRI. Furthermore, biparametric MRI of the 
prostate avoids any contrast agent side effects, improves 
cost-effectiveness, and optimizes general workflow in the 
radiology department. In addition, DCE sequences are 
deemed of diagnostic quality in only a subset of patients, 
as recently reported by the PRECISION study group [12]. 
However, as DCE-MRI is known to reduce the number 
of indeterminate lesions, and to be of particular value 
in examinations with poor image quality or for the less-
experienced radiologist [5, 13, 14], on-table monitoring 
and an individualized per-patient decision on DCE are 
currently proposed by the PI-RADS committee [15].
Ideally, the decision to inject a contrast agent should 
therefore be performed by an experienced radiologist on 
a per-scan and ad-hoc basis, and its application should 
be limited to those cases when it is deemed to improve 
clinical decision-making. However, given the expected 
rise in examinations due to the inclusion of prostate MRI 
into national and international urologic guidelines, such 
an individual and timely decision on every prostate MRI 
may not be feasible anymore in a clinical setting for most 
institutions.
Therefore, we sought to develop, train, and validate 
convolutional neural network (CNN) that would auto-
matically identify patients in whom acquisition of a 
DCE sequence would be beneficial. This would allow for 
shorter biparametric examinations for many patients and 
increase patient safety by the omission of contrast media 
injection while simultaneously avoiding a decreased diag-
nostic accuracy in those patients who would benefit from 
a complete multiparametric MRI protocol.
Materials and methods
Patient cohorts and image analysis
This study was approved by the institutional review board 
and the requirement for study-specific informed consent 
was waived. A retrospective search was performed on 
our prospectively maintained institutional database from 
02/01/2018 to 11/30/2019 for consecutive patients under-
going multiparametric prostate MRI (in accordance with 
PIRADS guidelines [5]) for suspicion of prostate cancer. 
Three distinctive cohorts were formed: (1) a group of 300 
multiparametric prostate MRI for training of the neural 
network (“training set”) (see Additional file 1: Appendix 
S1), (2) a group of 100 multiparametric prostate MRI 
for validation of the trained network (“validation set”) 
and (3) a group of 31 patients undergoing prostate MRI 
on a scanner from a different vendor (“different vendor 
set”). The MRI examinations included into the “train-
ing” and “validation” were performed in 363 patients 
(age at time of MRI: 64.4  years, mean PSA at time of 
MRI: 8.33 ng/ml). All MRI scans of the first two groups 
were performed on Siemens Skyra scanners (Siemens 
Healthineers, Erlangen, Germany) at a field strength of 
3 Tesla using a 60 Ch or 18 Ch phased-array body coil, 
while the “different vendor set” underwent examinations 
on a GE Discovery MR750w (GE Healthcare, Chicago, 
Illinois, USA) using a 16 Ch phased-array body coil at a 
field strength of 3 Tesla. Typical MRI parameters for axial 
T2—weighted and diffusion-weighted sequences can be 
found in Additional file 1: Table S1. Two board-certified 
radiologists with 10 and 7  years of experience in dedi-
cated prostate imaging (‘expert radiologists’ according 
to ESUR/ESUI consensus [16], O.F.D. and A.M.H., R1 
and R2) independently reviewed all examinations of the 
“training set”, “validation set” and “different vendor set” 
and scored whether DCE sequences would have been 
beneficial for diagnosis (regardless of the reason, e.g. 
distortions by rectal gas, low signal-to-noise-ratio etc.). 
After completion of readings a consensus was reached by 
the two readers by reviewing all examinations with dis-
crepant decisions. The resulting consensus on the “train-
ing set” was used as reference standard for training of the 
CNN. In addition, the “validation set” was reviewed by 
a technician (R3) with daily practice in acquiring pros-
tate MRI examinations and again the necessity of DCE 
sequences was noted.
Training and validation of a neural network
A detailed account including technical specifications 
of the neural network can be found in Additional file 1: 
Appendix S1. The accompanying PyTorch code and the 
training scheme can be found at https:// github. com/ 
ender kon/ Prost ateQC. git.
Development of the convolutional neural network was 
based on T2—weighted axial images and correspond-
ing diffusion-weighted images (b values of 100, 600 and 
1000  s/mm2). After exporting the anonymized image 
data of these sequences from PACS, images were pre-
processed to standardize pixel size across all images. The 
convolutional neural network was trained on a set of 300 
MRI examinations (“training set”) with the consensus on 
desirability of DCE by two experienced radiologists as 
reference standard and then applied to a separate set of 
100 MRI examinations not used for training (“validation 
set”). Separate branches for anatomical (T2—weighted) 
and diffusion-weighted images were created, whose 
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outputs were then reduced to receive a single probability 
(ranging from 0 to 1, with 0 meaning “DCE not desira-
ble” and 1 meaning “DCE highly desirable”). For training, 
10 random experiments were performed with the train-
ing set being split into training (80%), validation (5%) 
and testing partitions (15%) randomly, with the training 
partition being used to train the network, the validation 
partition being used to decide when to stop training and 
testing partition to monitor the error. The model was 
trained for 30 epochs for each random experiment, the 
iteration that led to the lowest classification error and 
cross-entropy loss on the validation set was determined 
to be the final model for experiment. While analyzing 
validation data, all 10 trained networks were applied sep-
arately, and results were aggregated through averaging 
to yield the final prediction for each image. The trained 
network was consecutively validated in a training set with 
images of 100 additional patients to evaluate its sensi-
tivity and specificity and in a separate set of 31 prostate 
MRIs performed on a scanner from a different MRI ven-
dor, see Fig. 1.
Statistics
To assess inter-reader agreement, Cohen’s kappa was 
estimated and interpreted as proposed by Landis and 
Koch [17] and as follows: excellent agreement > 0.75, 
good agreement 0.59–0.75, fair agreement 0.40–0.58, 
poor agreement < 0.4. Diagnostic accuracy was assessed 
by the area under the curve of a receiver-operator-char-
acteristics (ROC) analysis and the best cut-off value was 
estimated by maximizing the Youden index.
All statistical analyses were performed using IBM SPSS 
Statistics 26 (IBM Inc., Armonk, USA) and MedCalc 
18.2.1 (MedCalc Software Ltd, Ostend, Belgium).
Results
Inter‑reader agreement
R1 and R2 agreed on the necessity for DCE sequences in 
267/300 (89%) cases of the “training set” (kappa: 0.76), 
89/100 (89%) cases of the “validation set” (kappa: 0.76) 
and in 26/31 cases of the “different vendor set” (kappa: 
0.64). In the remaining examinations, a consensus read-
ing was needed to complete the standard of reference. 
Agreement between R3 (technician) and the reference 
standard (consensus of R1 and R2) for the “validation set” 
was fair with a kappa of 0.55 (see Table 1).
Diagnostic accuracy of the neural network
The final neural network showed a sensitivity of 94.4% 
and specificity of 68.8% in the “validation set” when 
maximizing the Youden index (AUC: 0.88, J: 0.63) in 
ROC analysis (see Fig.  2a). When aiming for a low rate 
of false negatives (a low re-examination rate for adding 
DCE sequences), this would result in 2% of all patients 
(and 2/36 patients with a need for DCE, 5.6%) needing 
a supplementary examination including the injection of 
a contrast agent (false negatives), while 44% of patients 
correctly underwent biparametric and 34% of patients 
correctly underwent multiparametric MRI (see Table 2). 
In 20% of patients, the CNN decided to perform DCE 
while the radiologists did not deem DCE to be necessary 
(false positives).
Fig. 1 Flow chart detailing the process of training and validation of a neural network for deciding on the necessity for DCE sequences. Consensus 
of two experienced radiologists was standard of reference for all comparisons
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With R3 (technician) reaching a sensitivity of 63.9% 
and specificity of 89.1%, the use of the neural network 
would allow for an increase in sensitivity of 30.5% at an 
albeit lower specificity (see Figs. 2b and 3).
When applying the trained neural networks to a set of 
MRI examinations from a different vendor, ROC analysis 
with maximized Youden index (AUC: 0.73, J: 0.42) dem-
onstrated a sensitivity of 100% and a specificity of 42.1% 
(see Table 3).
Discussion
Due to its necessity in order to perform targeted biop-
sies, the widespread integration of prostate MRI in the 
diagnostic workup of patients with suspected prostate 
cancer will likely lead to an increased number of exami-
nations to be performed by radiology departments in 
the near future [1]. This represents a challenge, as it not 
only requires improving the radiological workflow [18], 
but also ensuring optimal image quality of the exami-
nations, as stressed by the recently published PI-QUAL 
scoring system from the PRECISION trial group [12, 19]. 
We developed and validated a CNN to independently 
decide on the necessity of dynamic contrast-enhanced 
sequences (DCE) with high accuracy and with a very low 
false negative rate (i.e. a low rate of patients who falsely 
did not undergo DCE).
Multiparametric prostate MRI includes T2—weighted, 
diffusion-weighted and dynamic contrast-enhanced 
sequences. Recently, several authors suggested that 
dynamic contrast-enhanced sequences could be omit-
ted from the MRI protocol (“biparametric MRI”), 
thus shortening examination times and avoiding any 
Table 1 Performance of reader 3 (technician) and the artificial intelligence in correctly deciding on the necessity of contrast injection 
in the validation set (n = 100) with the consensus of two experienced radiologists (R1 and R2) as reference standard.
Agreement: kappa with Consensus as reference standard; AUC: Area-under-the-curve; Sensitivity and Specificity of the artificial intelligence based on ROC analysis 
with a maximized Youden index and high sensitivity to avoid re-examinations
DCE necessary DCE not necessary Agreement AUC (95% CI) Sensitivity Specificity
Consensus (R1/R2) 36/100 (36%) 64/100 (64%) Ref Ref Ref Ref
Technician (R3) 70/100 (70%) 30/100 (30%) 0.55 0.765 (0.669–0844) 63.9% 89.1%
Artificial Intelligence (AI) 56/100 (56%) 44/100 (44%) 0.54 0.881 (0.801–0.937) 94.4% 68.8%
Fig. 2 Receiver-Operating-Characteristic-Curves (ROC-Curves, numbers are percentages) of the diagnostic performance of the convolutional 
neural network in the “validation set” (a n = 100, AUC: 0.88) and “different vendor set” (b n = 31, AUC: 0.73).
Table 2 ROC analysis results with maximized Youden index from 
the validation set (n = 100)
“DCE necessary/not necessary” is based on the consensus of two expert 
radiologists
AI Artificial Intelligence
Radiologists: DCE necessary Radiologists: 
DCE not 
necessary
AI: DCE necessary 34/100 (34%) 20/100 (20%)
AI: DCE not necessary 02/100 (2%) 44/100 (44%)
Sensitivity: 94.4% Specificity: 68.8%
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potential unwanted side effects from the contrast agent 
[6, 7]. However, it is also known that contrast-enhanced 
sequences can be of value in a subset of patients under-
going prostate MRI [20, 21] and that they can be of par-
ticular value for the unexperienced radiologist and in 
examinations with artifacts (e.g., from hip prothesis) or 
poor image quality [14]. While previous papers focused 
on the use of AI in prostate MRI to improve planning and 
image quality of the examinations [18] or tumor detec-
tion [22, 23], we aimed to harness the benefits of artificial 
intelligence to improve quality control and workflow-rel-
evant decision making.
Ideally, the decision on whether to perform DCE 
should be made on a per-patient and ad-hoc basis, as 
currently proposed by the PI-RADS committee [15]. 
However, applying on-table monitoring and having a 
radiologist render this decision on a per-case basis often-
times is not feasible in clinical routine—and re-exam-
inations should be avoided particularly to not endanger 
the (time) benefits gained from not performing DCE 
sequences in every patient. In this study we sought to 
delegate the task of deciding between a biparametric 
and multiparametric protocol to artificial intelligence, 
which would allow for real-time decision-making and a 
straightforward implementation into the clinical work-
flow. The trained neural network was able to correctly 
decide on contrast agent application with a very high 
sensitivity of > 94%. This approach would have correctly 
assigned 44% of patients to a biparametric protocol—
thus sparing them from contrast injection—and 34% 
to a standard multiparametric MRI. Twenty percent of 
patients would have undergone multiparametric instead 
of biparametric MRI based on the algorithm’s decision. 
At the same time, only 2% of all patients (5.6% in the 
subgroup of patients with the need for DCE) would not 
have received DCE when expert radiologists would have 
deemed it necessary. Depending on the clinical question 
posed in these patients, they could be scheduled for a re-
examination. Finally, performance of the neural network 
was superior to the accuracy of the radiology technician 
acquiring the images (reader 3 in this study), i.e. it would 
be beneficial having the neural network deciding on DCE 
in clinical routine. This would particularly apply in a set-
ting where the biparametric MRI protocol is used as an 
institutional standard for detection of target lesions on 
prostate MRI. The AI could automatically detect a scan 
that might require the acquisition of DCE sequences with 
high accuracy and alert the attending radiologist (who 
still has to supervise the application of contrast agent due 
to legal reasons and the possibility for adverse reactions).
When applying the neural network trained on in-
house scanners to a set of MRI examinations performed 
on a different scanner, a sensitivity of 100% at an albeit 
lower specificity of 42.1% was achieved. While this is cer-
tainly an encouraging result and shows that the network 
is not restricted to images from scanners of a certain 
Fig. 3 66 year-old patient undergoing prostate MRI for suspicion for prostate cancer. The presence of rectal gas results in susceptibility artifacts, 
distorting the diffusion-weighted image (left: DWI, b = 1000 s/mm2; middle: T2—weighted). Both the experienced radiologists and the AI opted for 
contrast, while reader 3 (technician) did not. Dynamic contrast-enhanced MRI (right) was helpful in ruling out any index lesions at this level of the 
prostate
Table 3 Performance of the trained neural network in the validation set and in the set with scans from a different vendor (ROC 
analysis; AUC: Area-under-the-curve, Criterion: associated criterion) with consensus from two experienced radiologists as standard of 
reference
AUC (95% CI) Criterion Sensitivity (%) Specificity (%)
AI validation set 0.881 (0.801–0.937) > 0.221 94.4 68.8
AI different vendor set 0.726 (0.537–0.870) > 0.171 100.0 42.1
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manufacturer, a dedicated training set based on scans 
from this different vendor would likely further increase 
the accuracy of the neural network.
In addition, our approach could be improved and 
refined in a few ways: Though the testing set for the neu-
ral network consisted of sequentially acquired clinical 
MRI examinations, the artificial intelligence requires vali-
dation in clinical routine in the future. In this study, the 
decision rendered by the neural network was regarded as 
dichotomous—however, it would be possible to define a 
range of probability values in which the AI is unsure in 
its decision, which would prompt the technician to call a 
radiologist for this particular examination. This approach 
could reduce the number re-examinations, while still 
allowing for omittance of DCE in many cases. Also, the 
consensus of two “expert level” radiologists was used 
as standard of reference in this study. However, there 
might be cases in which a more novice reader would have 
appreciated a DCE sequence when the more experienced 
reader does not require it. In addition, while we assessed 
the performance of the neural network in a set of MRI 
examinations from a different vendor, the number of 
scans included into the “different vendor set” was rather 
low. However, as the code for the neural network will be 
freely available, our results can easily be tested in a differ-
ent institution and with different scanners.
In conclusion, we designed a neural network with the 
ability to accurately decide between acquisition of a full 
multiparametric MRI protocol including DCE and a 
faster biparametric protocol. The rate of patients who 
would have left the MRI scanner without an ultimately 
needed DCE sequence based on the decision made by the 
CNN was very low. Hence, integration of AI into quality 
assessment and decision making could allow for shorter 
examination times and a more streamlined clinical work-
flow, while maintaining diagnostic accuracy by including 
DCE only when truly needed.
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